The human and mouse MHC class III region: A parade of 21 genes at the centromeric segment

Immunology Today

Volumn 21, Issue 7, 2000, Pages 320-328

  Yung Yu, C ^a   Yang, Zhenyu ^a   Blanchong, Carol A ^a   Miller, Webb ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C2; DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3; NOTCH RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CENTROMERE; CONTROLLED STUDY; DEVELOPMENT; DIFFERENTIATION; DNA SEQUENCE; EXON; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC CODE; GROWTH; HUMAN; LIPID METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATOR GENE; SEQUENCE ANALYSIS; STEROID METABOLISM; STRUCTURAL GENE;

EID: 0034235121     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(00)01664-9     Document Type: Note

References (67)

1. Dawkins R.et al. Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol. Rev. 167:1999;275-304.
2. Trowsdale J. 'Both man & bird & beast': comparative organization of MHC genes. Immunogenetics. 41:1995;1-17.
3. The MHC Sequencing Consortium Complete sequence and gene map of a human major histocompatibility complex. Nature. 401:1999;921-923.
4. Yu C.Y. Molecular genetics of the human MHC complement gene cluster. Exp. Clin. Immunogenet. 15:1998;213-230.
5. Milner C.M., Campbell R.D. Genetic organization of the human MHC class III region. Pediatr. Path. Mol. Med. 2000;. (in press).
6. Campbell R.D., Trowsdale J. A map of the human major histocompatibility complex. Immunol. Today. 18:1997;. centerfold.
7. Gruen J.R., Weissman S.M. Human MHC class III and IV genes and disease associations. Pediatr. Path. Mol. Med. 2000;. (in press).
8. Awdeh Z.L.et al. Extended HLA/complement allele haplotypes: Evidence for T/t-like complex in man. Proc. Natl. Acad. Sci. U. S. A. 80:1983;259.
9. Carroll M.C.et al. A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature. 307:1984;237-241.
10. Chaplin D.et al. Molecular map of the murine S region. Proc. Natl. Acad. Sci. U. S. A. 80:1983;6947-6951.
11. Rowen, L. et al. (1997) Sequence of the mouse major histocompatibility locus class III region. GenBank, AF030001, AF049850.
12. Rowen, L. et al. (1998) Sequence of the mouse major histocompatibility locus class III region. GenBank, AF109906.
13. Li L.et al. Cloning, characterization, and the complete 56.8-kilobase DNA sequence of the human NOTCH4 gene. Genomics. 51:1998;45-58.
14. Yang Z.et al. Four ubiquitously expressed genes, RD (D6S45)-SKI2W (SKIV2L)-DOM3Z-RP1(D6S60E), are present between complement component genes factor B and C4 in the class III region of the HLA. Genomics. 53:1998;338-347.
15. Dangel A.W.et al. The dichotomous size variation of human complement C4 gene is mediated by a novel family of endogenous retroviruses which also establishes species-specific genomic patterns among Old World primates. Immunogenetics. 40:1994;425-436.
16. Shen L.et al. Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region: 263molecular cloning, exon intron structure, composite retroposon, and breakpoint of gene duplication. J. Biol. Chem. 269:1994;8466-8476.
17. Yang Z., Yu C.Y. Organization and gene duplications of the human and mouse MHC complement gene clusters. Exp. Clin. Immunogenet. 17:2000;1-17.
18. Yu C.Y. The complete exon-intron structure of a human complement component C4A gene: DNA sequences, polymorphism, and linkage to the 21-hydroxylase gene. J. Immunol. 146:1991;1057-1066.
19. Ikuta T.et al. Structural analysis of mouse tenascin-X: evolutionary aspects of reduplication of FNIII repeats in the tenascin gene family. Gene. 14:1998;1-13.
20. Allcock R.J.N.et al. Characterisation of the human central MHC gene, BAT1: genomic structure and expansion. Immunogenetics. 16:1999;98-106.
21. Blanchong C.A.et al. Deficiencies of human complement component C4A and C4B and heterozygosities in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians: the loads of RCCX genetic diversities on MHC-associated disease. J. Exp. Med. 2000;191.
22. Katsanis N.et al. (2000) Paralogy mapping: identification of a region in the human MHC triplicated onto human chromosomes 1 and 9 allows the prediction and isolation of novel PBX and NOTCH loci. Genomics. 35:1996;101-108.
23. Hardison R.C.et al. Long human-mouse sequence alignments reveal novel regulatory elements: a reason to sequence the mouse genome. Genome Res. 7:1997;959-966.
24. Makalowski W.et al. Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. Genome Res. 6:1996;846-857.
25. Murphy P.M. Molecular mimicry and the generation of host defense protein diversity. Cell. 72:1993;823-826.
26. 2 macroglobulin and complement components C3 and C4. Proc. Natl. Acad. Sci. U. S. A. 82:1985;9-13.
27. Atkinson J.P., Farries T. The separation of self and non-self in the complement system. Immunol. Today. 8:1987;212-215.
28. Yang Z.et al. Modular variations of HLA class III genes for serine/threonine kinase RP, complement C4, steroid 21-hydroxylase CYP21 and tensacin TNX (RCCX): a mechanism for gene deletions and disease associations. J. Biol. Chem. 274:1999;12147-12156.
29. Rupert K.L.et al. An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombinant between C4A and C4B genes in a patient with juvenile rheumatoid arthritis. Exp. Clin. Immunogenet. 16:1999;81-97.
30. Burch G.H.et al. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat. Genetics. 17:1997;104-108.
31. Levi-Strauss M.et al. Multiple duplications of complement C4 gene correlate with H-2-controlled testosterone-independent expression of its sex-limited isoform, C4-Slp. Proc. Natl. Acad. Sci. U. S. A. 82:1985;1746-1750.
32. Pattanakitsakul S.et al. Three extra copies of a C4-related gene in H-2w7 mice are C4/Slp hybrid genes generated by multiple recombinational events. Immunogenetics. 32:1990;431-439.
33. Chaplin D.D.et al. Nucleotide sequence analysis of murine 21-hydroxylase genes: mutations affecting gene expression. Proc. Natl. Acad. Sci. U. S. A. 83:1986;9601-9605.
34. Van Den Berg C.W.et al. Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. Proc. Natl. Acad. Sci. U. S. A. 89:1992;10711-10715.
35. Stavenhagen J.B., Robins D.M. An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. Cell. 55:1988;247-254.
36. Law S.K.A., Reid K.B.M. Complement. 1995;IRL Press at Oxford University Press.
37. Yamaguchi Y.et al. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell. 97:1999;41-51.
38. Qu X.et al. The human DEVH-box protein Ski2w from the HLA is located in nucleoli and ribosomes. Nucleic Acids Res. 26:1998;4068-4077.
39. Dangel A.W.et al. Human helicase gene SKI2W in the HLA class III region exhibits striking structural similarities to the yeast antiviral gene SKI2 and to the human gene KIAA0052: emergence of a new gene family. Nucleic Acids Res. 23:1995;2120-2126.
40. Masison D.et al. Decoying the cap‴ mRNA degradation system by a double stranded RNA virus and poly(A)‴ mRNA surveillance by a yeast antiviral system. Mol. Cell. Biol. 15:1995;2763-2771.
41. Xue Y.et al. Saccharomyces cerevisiae RAI1 (YGL246c) is homologous to DOM3Z and encodes a protein that binds the nuclear exoribonuclease Rat1p. Mol. Cell. Biol. 20:2000;4006-4015.
42. Gomez-Escobar N.et al. The G11 gene located in the major histocompatibility complex encodes a novel nuclear serine/threonine protein kinase. J. Biol. Chem. 273:1998;30954-30960.
43. Milner L.A., Bigas A. Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood. 93:1999;2431-2448.
44. Lewis J. Notch signalling and the control of cell fate choices in vertebrates. Semin. Cell Dev. Biol. 9:1998;583-589.
45. Struhl G., Adachi A. Nuclear access and action of notch in vivo. Cell. 93:1998;649-660.
46. Hardy J., Israel A. Alzheimer's disease. In search of γ-secretase. Nature. 398:1999;466-467.
47. De Strooper B.et al. A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain. Nature. 398:1999;518-522.
48. Struhl G., Greenwald I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature. 398:1999;522-525.
49. Ye Y.et al. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants. Nature. 398:1999;525-529.
50. Artavanis-Tsakonas S.et al. Notch signaling: cell fate control and signal integration in development. Science. 284:1999;770-776.
51. Uyttendaele H.et al. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development. 122:1996;2251-2259.
52. Burch G.H.et al. Embryonic expression of tenascin-X suggests a role in limb, muscle, and heart development. Dev. Dynamics. 203:1995;491-504.
53. Reichardt L.F. Kreis T., Vale R. Guidebook to the extracellular matrix and adhesion proteins. 1993;3-11 Oxford University Press.
54. Sakai T.et al. Tenascin-X expression in tumor cells and fibroblasts: glucocorticoids as negative regulators in fibroblasts. J. Cell Sci. 109:1996;2069-2077.
55. Mann R.S., Chan S-K. Extra specificity from extradenticle: the partnership between HOX and PBX/EXD homeodomain proteins. Trends Genet. 12:1996;258-262.
56. Aguado B., Campbell R.D. The novel gene G17, located in the human major histocompatibility complex, encodes PBX2, a homeodomain-containing protein. Genomics. 25:1995;650-659.
57. Berthelsen J.et al. Prep1, a novel functional partner of Pbx proteins. EMBO J. 17:1998;1423-1433.
58. Monica K.et al. PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. Mol. Cell Biol. 11:1991;6149-6157.
59. Leung D.W. The structure and functions of human lysophosphatidic acid transferases. Pediatr. Path. Mol. Med. 2000;. (in press).
60. Soyombo A.A., Hofmann S.L. Molecular cloning and expression of palmitoyl-protein thioesterase 2 (PPT2), a homolog of lysosomal palmitoyl-protein thioesterase with a distinct substrate specificity. J. Biol. Chem. 272:1997;27456-27463.
61. New M.I., Wilson R.C. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc. Natl. Acad. Sci. U. S. A. 96:1999;12790-12797.
62. Wautier J.L.et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc. Natl. Acad. Sci. U. S. A. 91:1994;7742-7746.
63. Yan S.D.et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
64. Hofmann M.A.et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 97:1999;889-901.
65. Yoshida H.et al. Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors. J. Biol. Chem. 273:1998;33741-33749.
66. Min J.et al. A novel Creb family gene telomeric of HLA-DRA in the HLA complex. Genomics. 30:1995;149-156.
67. Schwartz S.et al. Pipmaker-a web server for aligning two genomic DNA sequences. Genome Res. 10:2000;577-586.